Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Endurant Stent Graft System
This study is currently recruiting participants.
Verified by Medtronic Endovascular, June 2008
Sponsored by: Medtronic Endovascular
Information provided by: Medtronic Endovascular
ClinicalTrials.gov Identifier: NCT00705718
  Purpose

To demonstrate safety and effectivness in the treatment of Abdominal Aortic or Aorto-illiac Aneurysms.


Condition Intervention
Abdominal Aortic Aneurysms
Device: Endurant Stent Graft System

MedlinePlus related topics: Aneurysms
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Single Group Assignment
Official Title: Endurant Stent Graft System US Clinical Study

Further study details as provided by Medtronic Endovascular:

Primary Outcome Measures:
  • Treatment Success [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Safety and efficacy through 12 months [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 150
Study Start Date: June 2008
Estimated Study Completion Date: June 2013
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Single: Experimental Device: Endurant Stent Graft System
Abdominal Aortic Aneurysm Repair

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Morphology suitable for endovascular repair.
  • Adequate iliac/femoral access.
  • Subject is willing to comply with the protocol and undergo follow-up requirements

Exclusion Criteria:

  • Subject has a life expectancy < 1 year
  • Subject is participating in another investigational drug or device study
  • Subject requires emergent aneurysm treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00705718

Contacts
Contact: Peyton Willert, MPH 707-525-0111 peyton.willert@medtronic.com

Locations
United States, Pennsylvania
University of Pittsburg Medical Center Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
Medtronic Endovascular
Investigators
Principal Investigator: Michel S Makaroun, MD Division of Vascular Surgery University of Pittsburgh Medical Center
  More Information

Responsible Party: Medtronic Vascular ( Peyton Willert, MPH, Director of Endovascular Clinical Research )
Study ID Numbers: Medtronic - 089
Study First Received: June 24, 2008
Last Updated: June 25, 2008
ClinicalTrials.gov Identifier: NCT00705718  
Health Authority: United States: Food and Drug Administration

Keywords provided by Medtronic Endovascular:
The Endurant Stent Graft System is for the treatment of Abdominal Aortic Aneurysms

Study placed in the following topic categories:
Aortic Diseases
Aneurysm
Aortic Aneurysm, Abdominal
Abdominal aortic aneurysm
Vascular Diseases
Aortic Aneurysm

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009